Single-cell Omics Market Trends

Growth Drivers

• Rising Instances of Cancer– Cancer is a complex disease that consists of diverse cell populations with distinct genetic and phenotypic profiles. Single-cell omics provide a powerful tool to segregate cancer cells. By analyzing individual cancer cells, researchers can identify rare cell populations that contribute to tumor development progression, and response to therapy.
• Increasing Demand for Biologics– According to the Food and Drug Administration, the Center for Drug Evaluation and Research (CDER) authorized 37 innovative pharmaceuticals in 2022, either as new molecular entities (NMEs) through New Drug Applications (NDAs) or as new therapeutic biological products through Biologics License Applications (BLAs). Single-cell omics can aid in the section and optimization of cell aid in the selection and optimization of cell lines for biologics production.
• Development of Innovative Products– CellenCHIP 384 for single-cell omics sample preparation was introduced as an essential component in the new cellenCHIP 384 by SCIENION and Cellenion. It expands the cellenONE's robotic capacity for miniaturization and high productivity operations. The field of single-cell omics is rapidly evolving, driven by continuous advancements in technologies and methodologies. These technological advancements attract researchers and fuel the demand for these innovative products.

Challenges

• Single-Cell Omics Technique is Expensive- The need for specialized equipment, reagents, and data analysis resources adds to the overall cost. Affordability and cost-effectiveness of single-cell omics technologies are significant considerations for their widespread implementation, especially in resource-limited settings or for small research institutes.
• Technical Complications Associated with the Research
• Lack of Standardized Protocols and Benchmark Datasets